Capacitation and Ca2+ influx in spermatozoa: role of CNG channels and protein kinase G

Summary Cyclic guanosine monophosphate (cGMP) has been recently shown to modulate in vitro capacitation of mammalian spermatozoa, but the mechanisms through which it influences sperm functions have not been clarified. There are at least two targets of cGMP, cyclic nucleotide‐gated (CNG) channels and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Andrology (Oxford) 2014-01, Vol.2 (1), p.145-154
Hauptverfasser: Cisneros‐Mejorado, A., Hernández‐Soberanis, L., Islas‐Carbajal, M. C., Sánchez, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Cyclic guanosine monophosphate (cGMP) has been recently shown to modulate in vitro capacitation of mammalian spermatozoa, but the mechanisms through which it influences sperm functions have not been clarified. There are at least two targets of cGMP, cyclic nucleotide‐gated (CNG) channels and cGMP‐dependent protein kinase (PKG), involved in several physiological events in mammalian spermatozoa. It has been suggested that CNG channels allow the influx of Ca2+ to cytoplasm during capacitation, whereas PKG could trigger a phosphorylation pathway which might also, indirectly, mediate calcium entry. Using the patch‐clamp technique in whole‐cell configuration, we showed how l‐cis‐Diltiazem (a CNG‐channel inhibitor) and KT5823 (a PKG inhibitor) decreased significantly the amplitude of macroscopic ion currents in a dose–response manner, and decreased in vitro capacitation. The inhibition of CNG channels completely abolishes the Ca2+ influx induced by cyclic nucleotides in mouse spermatozoa. This work suggests that the downstream cGMP pathway is required in mammalian sperm capacitation and the mechanisms involved include CNG channels and PKG, highlighting these molecules as important therapeutic targets for infertility treatments or to develop new male contraceptives.
ISSN:2047-2919
2047-2927
DOI:10.1111/j.2047-2927.2013.00169.x